BDBM164793 US10604504, Example 232::US11623921, Example 232::US9688629, 231::US9688629, 232::US9802915, Example 232::US9920031, Example 232

SMILES C=CC(=O)N1Cc2cccc(-c3c(F)cc(C(N)=O)c4[nH]c(C)c(C)c34)c2C(F)(F)C1

InChI Key InChIKey=RWJOLNLBAJBYJS-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 164793   

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 0.100nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 0.100nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 0.100nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 0.100nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 0.100nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 3.40nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 3.40nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 3.40nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 3.40nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 164793BDBM164793(US9688629, 232 | US9688629, 231 | US9802915, Examp...)
Affinity DataIC50: 3.40nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent